-
br Raber Durlacher JE Brennan MT Verdonck de
2022-06-21
[48] Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM, et al. Swallowing dys-function in cancer patients. Support Care Cancer 2012;20(3):433–43. [49] Van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Hilgers FJ. Functional outcomes and rehabilitation strategies in patients treated with
-
VDR FokI br Olfat G Shaker Mahmoud A Senousy br
2022-05-30
VDR FokI Olfat G. Shaker, Mahmoud A. Senousy Table 4 Continued Combination Frequency, N (%) Adjusted OR SNP-SNP Interaction Genotype Genotype Control Combinations with zero frequencies in either group were omitted. Abbreviations: BC ¼ breast cancer; CI ¼ confidence interv
-
br Patient specific factors such as age underlying disease
2022-05-30
Patient-specific factors such as age, underlying disease, and surgical site have been identified as risk factors for intraoperative transfusion.4,5 In addition, intraoperative management of anticoagulation including antiplatelet therapy has been suggested to reduce intraoperative bleeding complica
-
Zlot AI Silvey K Newell N
2022-05-25
36. Zlot AI, Silvey K, Newell N, Coates RJ, Leman R. Family history of colorectal cancer: clinicians’ preventive recommendations and patient behavior. Prev Chronic Dis. 2012;9:E21. 37. Zlot A, Cox S, Silvey K, Leman R. The effect of chronic disease family Contents lists available at ScienceDir
-
br Corresponding author at Department of Oncology Cracow University
2022-05-25
Corresponding author at: Department of Oncology, Cracow University Hospital, 10 Sniadeckich St., 31-531, Cracow, Poland. E-mail address: [email protected] (A.L. Zygulska). 1 Passed away before the study was finished. Available online 21 November 2018 human studies [6,7]. An incre
-
Luna P rez P Rodr guez Ram rez S Vega
2022-05-25
6. Luna-Pérez P, Rodríguez-Ramírez S, Vega J, Sandoval E, Labastida S. Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma. Rev Invest Clin. 2001;53:388–95. 7. Maas CP, Moriya Y, Steup WH, Kiebert GM, Kranenbarg WM, van de Velde CJ. Radical and nerve-preserv
-
br Swinnen JV Brusselmans K Verhoeven
2022-05-23
37. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006; 9:358-65. 38. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformatio
-
br gemcitabine for and h The
2022-05-23
gemcitabine for 24, 48 and 72 h. The results showed that the sensitivity of the Z-VAD-FMK to gemcitabine increased with time in the aPKCι knockdown group (Fig. 5B and S4B). Notably, we also observed similar results that the loss of Nrf2 could help GBC cells to overcome the obstacle of che-more
-
br Dopa s release rate was observed The solubility of
2022-05-22
Dopa's release rate was observed. The solubility of L-Dopa is mainly influenced by the pH of the media. The decrease in the pH of an aqu-eous solution leads to increasing the solubility of L-Dopa. Therefore, L-Dopa released from [email protected] much faster in lower pHs. Also, reducing the pH of th
-
br Cell cytotoxicity was quantified
2022-05-22
Cell cytotoxicity was quantified by measuring the release of lactate dehydrogenase (LDH) from damaged or destroyed DMAPP into the media. Cytotoxicity was measured with the LDH Cytotoxicity Detection Kit (Roche, Germany). This kit detects LDH release from dead cells. Therefore, the increase of LDH
-
br that ITH exhibited lower IC as compared
2022-05-19
that ITH-6 exhibited lower IC50 as compared to the newer drugs, re-gorafenib and irinotecan. The difference in response to different colon cancer cell lines are due to their establishment from different origin and p53 mutation status Barretina, 2012). Inhibition of the cell proliferation has long
-
br overexpression of certain kinases is associated
2022-05-18
overexpression of certain kinases is associated with de novo or acquired resistance to MAPK-ERK inhibition; Johannessen et al. (2010, 2013) have identified resistance-driving candidate genes in viability assays using melanoma A375 cells. Seventeen of these candidates were analyzed in our screen, a
-
br Some ancillary cytological methods have already been
2022-05-18
Some ancillary cytological methods have already been tested in clinical studies which identified additional patients with malignancy over routine AEB071 without additional false positives. These include mutational analysis (ie, KRAS, p16, p53) [6], immunohistochemistry (ie, mesothelin) [7], DNA p
-
br for high school completion which means
2022-05-15
for high school completion, which means that a large proportion of Canadians would not be able to comprehend the majority of resources evaluated in this study [24]. The inability to read and comprehend resources available can have negative effects on cancer caregivers’ psychological and physical h
-
br Amplification of the genes located on
2022-05-13
Amplification of the genes located on 8p and 8q is summa-rized in Fig. 2A. Amplifications of FGFR1 and ZNF703 were observed at similar frequencies. By dual-color FISH, the sig-nals for ZNF703, FGFR1, ADAM5, and IKBKB, if amplified, were found to be closely associated, suggesting location on the sa